Search results

https://www.medarbetarwebben.lu.se/evenemang/knowledge-sustainable-development-2025-breaking-barriers-climate-solutions - 2026-05-20

https://www.lu.se/evenemang/knowledge-sustainable-development-2025-breaking-barriers-climate-solutions - 2026-05-20

The goal of this study is to investigate the applicability of asymmetrical flow field-flow fractionation (AsFlFFF)–multi angle laser light scattering (MALLS), and to develop a method for analysis of cationic potato amylopectin (CPAP) having ultrahigh molecular mass (UHMr). Use of the aqueous carrier having low salt content (3 mM NaN3) resulted in a distortion in AsFlFFF fractograms of CPAP with a

Project for Doctoral Studies in States of Consciousness (including hypnosis and dissociation) and Parapsychology Project for Doctoral Studies in States of Consciousness and Parapsychology (handledning på svenska eller engelska) As part of a long-term program of research in states of consciousness and anomalous psychology, my associates and I at the Center for Research on Consciousness and Anomalou

https://www.psy.lu.se/en/sites/psy.lu.se.en/files/states_of_consciousness_and_parapsychology.doc - 2026-05-20

2 At the Forefront of Nanoscience NanoLund is the center for research, education and innovation within nanoscience at Lund University. NanoLund engages more than 400 persons including researchers, students and staff, within the faculties of engineering, science and medicine. It is a strategic research area funded by the Swedish Government, and Sweden’s largest research environment for nanoscience

https://www.nano.lu.se/sites/nano.lu.se/files/2023-07/NanoLund_Broschyr%202023_FINAL.pdf - 2026-05-20

Dreams & Discoveries LTH / FACULTY OF ENGINEERING / LUND UNIVERSITY Content: A place for dreams and disco veries .............. 3 To benefit the climate .................................... 8 To benefit digitalization .............................. 12 To benefit Industry ....................................... 16 To benefit the built environment ............... 20 To benefit life .................

https://www.lth.se/fileadmin/lth/english/Dreams_discoveries.pdf - 2026-05-18

Lägg till titel Sida 1 av 6 Beslutad i Utbildningsnämnden för ML 2024-06-12 Litteraturlista – KUME31, Bedömning, betygsättning och specialpedagogiska perspektiv, 10,5hp • Bedömning och betygssättning Carlgren, I., Forsberg, E., & Lindberg, V. (2009). Perspektiv på den svenska skolans kunskapsdiskussion. (s. 11–39). Stockholms universitetsförlag. https://www.diva- portal.org/smash/get/diva2:371489/

https://www.mhm.lu.se/sites/mhm.lu.se/files/2024-06/Litteraturlista%20KUME31%20Bed%C3%B6mning,%20betygs%C3%A4ttning%20och%20specialpedagogiska%20perspektiv.pdf - 2026-05-20

This thesis concerns the legal consequences and the economic effects of the use of a damages clause (avtalsvite). Starting from a rather routinely picture in the legal literature, the thesis seeks to establish a more sophisticated application of the clause, in order to maximize the parties total utility.Thanks to their long-standing use, there is a generally accepted picture of what damages clauseThis thesis concerns the legal consequences and the economic effects of the use of a damages clause (avtalsvite). Starting from a rather routinely picture in the legal literature, the thesis seeks to establish a more sophisticated application of the clause, in order to maximize the parties total utility.Thanks to their long-standing use, there is a generally accepted picture of what damages clause

BACKGROUND: Tofacitinib is a Janus kinase inhibitor for the treatment of ulcerative colitis (UC). Prospective real-world data are scarce.OBJECTIVES: To collect data on clinical outcomes, including health-related quality of life (HRQoL) and fatigue during treatment with tofacitinib.DESIGN: This is a prospective observational multicentre study in Sweden. In this analysis, outcomes at weeks 2, 8 and

Moraxella catarrhalis is a human-specific commensal of the respiratory tract and an opportunistic pathogen. It is one of the leading cause of otitis media in children and of acute exacerbations in patients with chronic obstructive pulmonary disease, resulting in significant morbidity and economic burden. Vaccines and new immunotherapeutic strategies to treat this emerging pathogen are needed. Comp

Streptococcus pyogenes is an exclusively human pathogen that can provoke mild skin and throat infections but can also cause fatal septicemia. This gram-positive bacterium has developed several strategies to evade the human immune system, enabling S. pyogenes to survive in the host. These strategies include recruiting several human plasma proteins, such as the complement inhibitor, C4b-binding prot